urea and pr-104a

urea has been researched along with pr-104a in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benito, J; Bohlander, SK; El-Hoss, J; Foehrenbacher, A; Gu, Y; Guise, CP; Jamieson, SM; Jing, D; Konopleva, M; Lock, RB; Mackenzie, KL; Manesh, DM; Mulaw, MA; Patterson, AV; Pullen, SM; Smaill, JB; Wilson, WR	1

Other Studies

1 other study(ies) available for urea and pr-104a

Article	Year
A novel fluorometric assay for aldo-keto reductase 1C3 predicts metabolic activation of the nitrogen mustard prodrug PR-104A in human leukaemia cells. Biochemical pharmacology, 2014, Mar-01, Volume: 88, Issue:1 Topics: 3-Hydroxysteroid Dehydrogenases; Aerobiosis; Aldo-Keto Reductase Family 1 Member C3; Antineoplastic Agents; Bone Marrow; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Fluorometry; HCT116 Cells; Heterocyclic Compounds, 4 or More Rings; Humans; Hydroxyprostaglandin Dehydrogenases; Leukocytes; Morpholines; Nitrogen Mustard Compounds; Oxidation-Reduction; Prodrugs; Substrate Specificity; Time Factors; Urea	2014

Article

Year

A novel fluorometric assay for aldo-keto reductase 1C3 predicts metabolic activation of the nitrogen mustard prodrug PR-104A in human leukaemia cells.

Biochemical pharmacology, 2014, Mar-01, Volume: 88, Issue:1

Topics: 3-Hydroxysteroid Dehydrogenases; Aerobiosis; Aldo-Keto Reductase Family 1 Member C3; Antineoplastic Agents; Bone Marrow; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Fluorometry; HCT116 Cells; Heterocyclic Compounds, 4 or More Rings; Humans; Hydroxyprostaglandin Dehydrogenases; Leukocytes; Morpholines; Nitrogen Mustard Compounds; Oxidation-Reduction; Prodrugs; Substrate Specificity; Time Factors; Urea

2014